Thanks Serb, those estimates are reasonable. I just experienced some unicorn gains on a ticker without REVENUE, so I believe that in the current OTC climate, the unexpected can happen. If there is any ticker on the OTC that DESERVES unicorn gains, it's RXMD! IMO